Sivasubramanian Dhiran, Balasubramanian Karthick, Sanil Sathwik, Aravind Smrti, Senthilkumar Virushnee
Department of Cardiology, Children's hospital of Philadelphia, PA, USA.
Department of Critical Care Medicine, Christian Medical College, Vellore, India.
Radiol Case Rep. 2025 May 17;20(8):3855-3858. doi: 10.1016/j.radcr.2025.04.094. eCollection 2025 Aug.
Hereditary pulmonary alveolar proteinosis (hPAP) is a rare disorder caused by mutations in the CSF2RA or CSF2RB genes, leading to impaired surfactant clearance by alveolar macrophages and subsequent respiratory dysfunction. A 5-year-old female with a 2-year history of poor weight gain, fatigue, and intermittent fever was evaluated. Clinical evaluation revealed hypoxemia, while high-resolution computed tomography (HRCT) of the chest showed the characteristic "crazy-paving" pattern suggestive of PAP. Bronchoalveolar lavage (BAL) yielded milky fluid with periodic acid-Schiff (PAS)-positive material, and genetic testing confirmed a homozygous mutation in the CSF2RA gene, consistent with hPAP. The patient underwent therapeutic whole lung lavage (WLL), resulting in significant clinical improvement. This case underscores the challenges of diagnosing pediatric hPAP and the value of integrating imaging, pathology, and genetic testing. While WLL remains the mainstay of treatment, further research is needed to develop targeted therapies.
遗传性肺泡蛋白沉积症(hPAP)是一种由CSF2RA或CSF2RB基因突变引起的罕见疾病,导致肺泡巨噬细胞清除表面活性物质受损,进而引发呼吸功能障碍。对一名有2年体重增长缓慢、疲劳和间歇性发热病史的5岁女性进行了评估。临床评估发现低氧血症,而胸部高分辨率计算机断层扫描(HRCT)显示出提示肺泡蛋白沉积症的典型“铺路石征”。支气管肺泡灌洗(BAL)得到乳白色液体,其中含有过碘酸希夫(PAS)阳性物质,基因检测证实CSF2RA基因存在纯合突变,符合hPAP。该患者接受了治疗性全肺灌洗(WLL),临床症状得到显著改善。本病例强调了小儿hPAP诊断的挑战以及整合影像学、病理学和基因检测的价值。虽然WLL仍然是主要治疗方法,但仍需要进一步研究以开发靶向治疗方法。